Agilent Technologies (A)

• Market cap: $38.7B
• 1 day: -0.21%
• 5 days: 2.01%
• 1 month: 1.07%
• 3 months: -7.45%
• 6 months: 2.04%
• Year to date: -2.12%
• 1 year: -2.86%
• 5 years: 58.94%
• 10 years: 228.20%
• Sector: Industrials
• Industry: Laboratory Analytical Instruments

About: Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

Employees: 17,400

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

35% more first-time investments, than exits

New positions opened: 130 | Existing positions closed: 96

9% more capital invested

Capital invested by funds: $33.6B [Q2] → $36.7B (+$3.05B) [Q3]

3% more funds holding

Funds holding: 994 [Q2] → 1,028 (+34) [Q3]

10% less repeat investments, than reductions

Existing positions increased: 339 | Existing positions reduced: 375

4.03% less ownership

Funds ownership: 89.02% [Q2] → 85.0% (-4.03%) [Q3]

8% less funds holding in top 10

Funds holding in top 10: 13 [Q2] → 12 (-1) [Q3]

24% less call options, than puts

Call options by funds: $122M | Put options by funds: $162M

Research analyst outlook

6 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $135 1% downside
• Avg. target: $147 8% upside
• High target: $160 18% upside

6 analyst ratings

• positive: 2 33%
• neutral: 3 50%
• negative: 1 17%

B of A Securities Derik De Bruin 26% 1-year accuracy 5 / 19 met price target	10% upside $150	Neutral Maintained	13 Dec 2024
Wells Fargo Brandon Couillard 22% 1-year accuracy 4 / 18 met price target	14% upside $155	Overweight Maintained	9 Dec 2024
Barclays Luke Sergott 25% 1-year accuracy 12 / 48 met price target	1% downside $135	Underweight Maintained	27 Nov 2024
Bernstein Eve Burstein 67% 1-year accuracy 4 / 6 met price target	1% downside $135	Market Perform Maintained	26 Nov 2024
JP Morgan Rachel Vatnsdal 47% 1-year accuracy 8 / 17 met price target	18% upside $160	Overweight Maintained	26 Nov 2024